Free Trial

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Shares Down 0.8% - Time to Sell?

RHÖN-KLINIKUM Aktiengesellschaft logo with Medical background

Key Points

  • RHÖN-KLINIKUM Aktiengesellschaft's stock price decreased by 0.8%, trading at €11.80 ($13.72) during mid-day on Monday.
  • The company has a market capitalization of $784.27 million and a price-to-earnings ratio of 17.48.
  • Trading volume saw a significant decline, with only 147 shares changing hands, drastically down from an average of 43,281 shares.
  • MarketBeat previews the top five stocks to own by October 1st.

Shares of RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK - Get Free Report) were down 0.8% during mid-day trading on Monday . The company traded as low as €11.80 ($13.72) and last traded at €11.80 ($13.72). Approximately 147 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 43,281 shares. The stock had previously closed at €11.90 ($13.84).

RHÖN-KLINIKUM Aktiengesellschaft Stock Down 0.8%

The company has a market cap of $790.92 million, a P/E ratio of 17.63, a price-to-earnings-growth ratio of 26.77 and a beta of -0.13. The company has a fifty day moving average of €11.91 and a 200 day moving average of €13.13.

About RHÖN-KLINIKUM Aktiengesellschaft

(Get Free Report)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.

Recommended Stories

Should You Invest $1,000 in RHÖN-KLINIKUM Aktiengesellschaft Right Now?

Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.

While RHÖN-KLINIKUM Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.